ArticleCancer research2014

Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance.

Shigeo Ohba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.